PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) announced the recent appointment of Marella Thorell and Dr. David Scadden to its Board of Directors, which became effective June 30, 2024. This leadership change comes as Regina Hodits and Björn Odlander step down from their roles, citing other professional commitments.
Sanford Zweifach, Chair of the Carisma Board of Directors, welcomed the new members. “We are pleased to welcome David and Marella to the Carisma Board of Directors. Their vast experience in the life sciences sector will be instrumental in advancing our cell therapy platform focused on engineered macrophages,” he said. Zweifach also expressed gratitude to Hodits and Odlander for their contributions, wishing them success in their future endeavors.
Dr. Scadden, a highly regarded physician and medical researcher, brings extensive expertise to Carisma. His background will be crucial as the company continues to develop its innovative cell therapy platform. Ms. Thorell, with her experience as a public company executive and board member of biotech firms, will enhance the business acumen of the board.
Steven Kelly, President and CEO of Carisma, emphasized the significance of these appointments. “Dr. Scadden’s renowned expertise as a physician and medical researcher will be incredibly valuable to Carisma, and we are honored to welcome him to our Board of Directors. Ms. Thorell’s experience as a public company executive and board member of biotech companies will enhance the business capabilities of our Board,” he stated. Kelly added that the new appointments would enrich the board’s diversity of experience and perspectives, providing exemplary leadership as Carisma works urgently to bring groundbreaking immunotherapies to patients.
The changes in the board composition aim to strengthen Carisma’s leadership team as the company advances its pioneering work in engineered macrophages for cell therapy.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.